Nobody could have predicted the vogue for GLP-1 drugs, which were originally designed to treat Type 2 diabetes
It means the legal standard for proving manufacturer liability is higher for these specific conditions at this stage
[13] Animal models [edit] Knockout mice of GPX4 die at embryonic day 8 [14] [15] and conditional inducible deletion in adult mice (neurons) results in degeneration and death in less than a month
As a result, a meta-analysis of 13 RCTs revealed that GLP-1 RAs, including liraglutide, semaglutide, and dulaglutide, are associated with a 23% increased risk of rapid worsening of diabetic retinopathy in T2DM (OR, 1.23
Considering Life Extension promotes its consistent, high-quality testing, we were surprised by these results